Quality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-8.60%
EBIT to Interest (avg)
-19.41
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.82
EV to EBIT
-5.53
EV to EBITDA
-6.00
EV to Capital Employed
25.41
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-459.48%
ROE (Latest)
-105.09%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
4What is working for the Company
PRE-TAX PROFIT(Q)
At HKD -26.27 MM has Grown at 78.56%
NET PROFIT(Q)
At HKD -28.38 MM has Grown at 76.45%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for TYK Medicines, Inc.
Pre-Tax Profit
At HKD -26.27 MM has Grown at 78.56%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -28.38 MM has Grown at 76.45%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Footer loading






